Skip to main content
Clinical Trials/NCT04525690
NCT04525690CompletedNot Applicable

Improving Inpatient Screening for Hepatitis C: A Stepped-Wedge Randomized Clinical Trial

University of Pennsylvania1 site in 1 country7,634 target enrollmentStarted: September 21, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
7,634
Locations
1
Primary Endpoint
Change in percentage of eligible patients that receive HCV antibody screening

Study Overview

Brief Summary

This study will use a stepped-wedge cluster randomized clinical trial to evaluate a health system initiative to set defaults in the electronic health record admission order set to nudge inpatient hepatitis C (HCV) screening.

Detailed Description

The hepatitis C virus (HCV) is the leading cause of liver transplant and hepatocellular carcinoma in the United States, but direct-acting antiviral medications are now available and can cure the disease in over 95% of those that are treated. The Centers for Disease Control and Prevention (CDC) estimate that 75% of all chronic HCV infections in the United States are among adults born between 1945 and 1965. The CDC and US Preventive Services Task Force (USPTF) therefore recommends birth cohort screening for all adults born in this time period. In 2016, the Commonwealth of Pennsylvania signed into law a requirement that all hospitalized patients born during this time period be offered HCV screening. In this study, a stepped-wedge cluster randomized clinical trial will be conducted to test the effect of defaulting HCV screening into the admission order set to improve screening rates.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Health Services Research
Masking
Double (Investigator, Outcomes Assessor)

Masking Description

The principal study investigator and data analyst will not have knowledge of when the hospital sites are randomized to the intervention.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Be admitted to the Hospital of the University of Pennsylvania (HUP) or Penn Presbyterian Medical Center (PPMC)
  • •Born between 1945 and 1965

Exclusion Criteria

  • •Patients will be excluded if they have already received Hepatitis C screening or have been previously diagnosed with Hepatitis C.

Arms & Interventions

HCV Screening Default-1 Hospital Crossed Over

Experimental

Upon entering the admission order set in the EHR clinicians will receive a default order for HCV screening for eligible patients. Clinicians will have the opportunity to opt-out and not order screening

Intervention: Nudge (Behavioral)

HCV Screening Default-2 Hospitals Crossed Over

Experimental

Upon entering the admission order set in the EHR clinicians will receive a default order for HCV screening for eligible patients. Clinicians will have the opportunity to opt-out and not order screening.

Intervention: Nudge (Behavioral)

Outcomes

Primary Outcomes

Change in percentage of eligible patients that receive HCV antibody screening

Time Frame: 6 months

The change in the percentage of eligible hospitalized patients that receive HCV antibody screening

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials